PRACOH Prevention Breakdown Support Advice Guidance Disability
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPôle Saint Hélier
About this trial
The main objective of this prospective interventional study is to evaluate the impact of the stay in the dedicated transitional care unit, through the achievement of the patient's primary objective set at admission, directly related to their specific needs.
It is expected to improve knowledge regarding the prevention of situations of breakdown and exhaustion in the living environment of people with disabilities.
* This would improve the life and care pathways as well as the support provided to these individuals and their families and friends. * It would limit the use of unscheduled care services in crisis situations, thereby improving the quality of care and life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
People with disabilities requiring a 4-week stay in a dedicated transitional care unit at POLE MPR ST HELIER
Men or women, of legal age (over 18)
Affiliated with a social security scheme or entitled to benefits
Having given their free and informed consent
Disqualifiers
Pregnant women, women in labor, or women who are breastfeeding
Individuals deprived of their liberty by judicial (excluding guardianship or curatorship) or administrative decision
Individuals undergoing severe psychiatric treatment that may impact the conduct of the protocol, at the investigator's discretion
Individuals in an emergency situation who are unable to give their prior consent.
Trial design
Design model
Single group
Treatments tested in this trial
the impact of the stay in the dedicated transitional care unit by evaluating whether the patient's primary objective, set at admission and directly related to their specific needs, has been achieved.
Other interventionassess the impact of the stay in the dedicated transitional care unit by evaluating whether the patient's primary objective, set at admission and directly related to heir specific needs, has been achieved.
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: INTERVENTIONALOther 1 intervention
Trial outcomes
Primary outcomes
1
The main objective of this prospective interventional study is to evaluate the impact of the stay in the dedicated transitional care unit, through the achievement of the patient's main objective set at admission, directly related to their specific needs.
The primary endpoint is the level of achievement of the patient's primary objective, defined upon admission, after a stay in the dedicated transitional care unit. This objective of the stay is defined using a 5-level GAS (Goal Attainment Scale) with 5 levels (from -2 (initial level) to +2 (level achieved beyond the objective)). The GAS is an assessment method focused on the personalisation of care or intervention objectives. It is co-constructed between the patient and the professional and reviewed by an expert trained in the GAS.
Time frame
inclusion * 1 month after the staySecondary outcomes
1
Evaluate the impact of the stay in the dedicated transitional care unit by assessing whether the caregiver's primary objective has been achieved, if the caregiver participates in the study.
Level of achievement of the caregiver's primary goal, defined in the week following the patient's admission and assessed one month after the end of the stay using a 5-level GAS scale (as for the patient in the primary endpoint).
Time frame
at the inclusion and one month after the stay2
Evaluate the main factor explaining the change in the objective perceived by the patient or caregiver and that perceived by the physician.
The data will be examined using a descriptive approach, with the aim of identifying the individual factors identified by the patient (or cargiver) and the physician. If the number of distinct factors allow it, their frequencies will be reported; otherwise, a qualitative descriptive analysis will be conducted. A comparison between the factors identified by the participant and those identified by the physician will also be performed.
Time frame
one month after the stay3
Assess changes in the patient's anxiety and depression levels following their stay in the dedicated transitional care unit.
Patient anxiety and depression levels as measured by the Hospital Anxiety and Depression Scale (HAD) anxiety score Interpretation: The HAD (Hospital Anxiety and Depression) scale is a tool used to screen for anxiety and depressive disorders. Seven questions (odd-numbered items) relate to anxiety, and seven others (even-numbered items) relate to depression, yielding two scores (maximum score for each scale = 21). The following interpretation can be applied to each score: * 7 or less: no symptoms. * 8 to 10: questionable symptoms. * 11 or more: definite symptoms.
Time frame
at the inclusion and one month after the stay4
Evaluate changes in the caregiver's anxiety and depression levels following their stay in the dedicated transitional care unit, if the caregiver participates in the study.
Caregiver anxiety and depression levels based on the anxiety score on the Hospital Anxiety and Depression Scale (HAD)
Time frame
at the inclusion and one month after the staySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov